OmniGene Bioproducts possesses core competencies and proprietary technologies
in the areas of industrial strain development.
OmniGene Bioproducts was formed in 1995 to focus on the company's strain
development platform. The new company brought the intellectual property
and strain libraries from OmniGene (formed in 1991) and BioTechnica International
(formed in 1981).
OmniGene Bioproducts' staff includes scientists with a broad range of
expertise in molecular biology, cell biology, and fermentation technology.
Through our core competency of metabolic pathway engineering, OmniGene
Bioproducts is positioned to leverage advances in key technologies. We
build value for ourselves and our partners through the creation of proprietary
technology and strains.